SEC Form 4 · accession 0001209191-19-011123
SCYNEXIS INC · SCYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gonzalez David Angulo
Officer — Chief Medical Officer
Period of report
Feb 15, 2019
Accepted (ET)
Feb 19, 2019 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2019 | A | 150,000 | $0.00 | A | 271,790 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.38 | Feb 15, 2019 | A | 150,000 | A | — | Feb 14, 2029 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Represents restricted stock units that vest 25% per year over four years.
- F21/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.